(Hypertension. 1996;27:190-196.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Medicine, Western General Hospital, University of Edinburgh (Scotland, UK), and the Research Institute, Children's Hospital, Oakland, Calif (C.H.L.S.).
Abstract Glucocorticoids raise blood pressure but were
thought not to play a pathophysiological role
in essential hypertension when it was demonstrated that cortisol
secretion rates and circulating concentrations are normal in this
disease. However, recent observations suggest that increased tissue
sensitivity to cortisol, mediated by either abnormal glucocorticoid
receptors or impaired inactivation of cortisol by
11ß-dehydrogenase, may allow cortisol to raise blood pressure
despite normal circulating concentrations. We studied 11 patients with
essential hypertension and 11 matched normotensive control subjects.
Dermal vasoconstriction after topical application of both cortisol
(16±4 versus 32±5 U, control subjects versus hypertensive
patients;
P<.02) and beclomethasone dipropionate (75±10 versus
100±7 U; P<.05) was increased in the hypertensive
patients. Hypothalamic-pituitary glucocorticoid receptor
sensitivity was normal, as judged by basal cortisol secretion rates and
suppression of plasma cortisol during sequential overnight
dexamethasone suppression tests. 11ß-Dehydrogenase
activity was impaired in essential hypertension, as judged by prolonged
half-lives of [11
-3H]cortisol (44±4 versus
58±4
minutes, control subjects versus hypertensive patients;
P<.02). However, this did not correlate with the dermal
vasoconstrictor response. We conclude that vasoconstrictor sensitivity
to glucocorticoids is increased in essential hypertension and that this
may initiate and/or sustain the increased peripheral
vascular resistance that characterizes this disease. The mechanism of
increased sensitivity remains uncertain, but it will be important to
establish whether it relates to genetic abnormalities of the
glucocorticoid receptor that have been observed in animal models and
young individuals who are predisposed to essential hypertension.
Key Words: glucocorticoids hypertension, essential skin vasoconstriction receptors, glucocorticoid metabolism
This article has been cited by other articles:
![]() |
V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis Rheumatology, January 1, 2008; 47(1): 72 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R Walker Glucocorticoids and Cardiovascular Disease Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. F. Panoulas, K. M. J. Douglas, H. J. Milionis, A. Stavropoulos-Kalinglou, P. Nightingale, M. D. Kita, A. L. Tselios, G. S. Metsios, M. S. Elisaf, and G. D. Kitas Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis Rheumatology, September 1, 2007; 46(9): 1477 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chamarthi, N. S. Kolatkar, S. C. Hunt, J. S. Williams, E. W. Seely, N. J. Brown, L. J. Murphey, X. Jeunemaitre, and G. H. Williams Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1340 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Atanasov, I. D. Ignatova, L. G. Nashev, B. Dick, P. Ferrari, F. J. Frey, and A. Odermatt Impaired Protein Stability of 11beta-Hydroxysteroid Dehydrogenase Type 2: A Novel Mechanism of Apparent Mineralocorticoid Excess J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1262 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bechtold and D. A. Scheuer Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Schachner, C. Lamerson, M. P. Sheehan, M. Boguniewicz, J. Mosser, S. Raimer, T. Shull, E. Jaracz, and for the US Tacrolimus Ointment Study Group Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study Pediatrics, September 1, 2005; 116(3): e334 - e342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gold, I. Dziobek, K. Rogers, A. Bayoumy, P. F. McHugh, and A. Convit Hypertension and Hypothalamo-Pituitary-Adrenal Axis Hyperactivity Affect Frontal Lobe Integrity J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3262 - 3267. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. DeLano, R. Balete, and G. W. Schmid-Schonbein Control of oxidative stress in microcirculation of spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H805 - H812. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393. [Abstract] [Full Text] |
||||
![]() |
D. A. Scheuer, A. G. Bechtold, S. S. Shank, and S. F. Akana Glucocorticoids act in the dorsal hindbrain to increase arterial pressure Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H458 - H467. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shank and D. A. Scheuer Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitarius Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1751 - H1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Andrews, O. Herlihy, D. E. W. Livingstone, R. Andrew, and B. R. Walker Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5587 - 5593. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and A. G. Bechtold Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R475 - R483. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.F. Hadoke, C. Christy, Y. V. Kotelevtsev, B. C. Williams, C. J. Kenyon, J. R. Seckl, J. J. Mullins, and B. R. Walker Endothelial Cell Dysfunction in Mice After Transgenic Knockout of Type 2, but Not Type 1, 11{beta}-Hydroxysteroid Dehydrogenase Circulation, December 4, 2001; 104(23): 2832 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Patel, J K Wales, M S Kibirige, A A Massarano, J M Couriel, P E Clayton, and G. RUSSELL Symptomatic adrenal insufficiency during inhaled corticosteroid treatment Arch. Dis. Child., October 1, 2001; 85(4): 330 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and A. G. Bechtold Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1719 - R1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer and S. W. Mifflin Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1440 - R1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Whitworth, G. J. Mangos, and J. J. Kelly Cushing, Cortisol, and Cardiovascular Disease Hypertension, November 1, 2000; 36(5): 912 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ebrecht, A. Buske-Kirschbaum, D. Hellhammer, S. Kern, N. Rohleder, B. Walker, and C. Kirschbaum Tissue Specificity of Glucocorticoid Sensitivity in Healthy Adults J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3733 - 3739. [Abstract] [Full Text] |
||||
![]() |
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension Hypertension, December 1, 1999; 34(6): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takami, Z. Y. H. Wong, M. Stebbing, and S. B. Harrap Linkage analysis of glucocorticoid and beta 2-adrenergic receptor genes with blood pressure and body mass index Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1379 - H1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christ and M. Wehling Cardiovascular steroid actions: swift swallows or sluggish snails? Cardiovasc Res, October 1, 1998; 40(1): 34 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Panarelli, C. D. Holloway, R. Fraser, J. M. C. Connell, M. C. Ingram, N. H. Anderson, and C. J. Kenyon Glucocorticoid Receptor Polymorphism, Skin Vasoconstriction, and Other Metabolic Intermediate Phenotypes in Normal Human Subjects J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1846 - 1852. [Abstract] [Full Text] |
||||
![]() |
B. R. Walker, D. I.W. Phillips, J. P. Noon, M. Panarelli, R. Andrew, H. V. Edwards, D. W. Holton, J. R. Seckl, D. J. Webb, and G. C. M. Watt Increased Glucocorticoid Activity in Men With Cardiovascular Risk Factors Hypertension, April 1, 1998; 31(4): 891 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H.M. van Uum, A. R.M.M. Hermus, P. Smits, T. Thien, and J. W.M. Lenders The role of 11{beta}-hydroxysteroid dehydrogenase in the pathogenesis of hypertension Cardiovasc Res, April 1, 1998; 38(1): 16 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. W. Phillips, D. J. P. Barker, C. H. D. Fall, J. R. Seckl, C. B. Whorwood, P. J. Wood, and B. R. Walker Elevated Plasma Cortisol Concentrations: A Link between Low Birth Weight and the Insulin Resistance Syndrome? J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 757 - 760. [Abstract] [Full Text] |
||||
![]() |
D. S. Gardner, A. A. Jackson, and S. C. Langley-Evans Maintenance of Maternal Diet-Induced Hypertension in the Rat Is Dependent on Glucocorticoids Hypertension, December 1, 1997; 30(6): 1525 - 1530. [Abstract] [Full Text] |
||||
![]() |
P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocr. Rev., February 1, 1997; 18(1): 135 - 156. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |